Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v1-EN
Language French English
Date Updated 2017-03-27 2017-03-27
Drug Identification Number 02278383 02278383
Brand name VANTAS VANTAS
Common or Proper name HISTRELIN ACETATE HISTRELIN ACETATE
Company Name PALADIN LABS INC. PALADIN LABS INC.
Ingredients HISTRELIN ACETATE HISTRELIN ACETATE
Strength(s) 50MG 50MG
Dosage form(s) IMPLANT KIT IMPLANT KIT
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 1 vial 1 vial
ATC code L02AE L02AE
ATC description HORMONES AND RELATED AGENTS HORMONES AND RELATED AGENTS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2006-07-15 2006-07-15
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments